TGF-β and cancer

被引:353
|
作者
Bierie, B
Moses, HL
机构
[1] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
关键词
TGF-beta; Smad; cancer; stroma; epithelium; interactions; cross-talk;
D O I
10.1016/j.cytogfr.2005.09.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TGF-beta signaling regulates tumorigenesis and ill human cancer its signaling pathways are often modified during tumor progression. Prior to initiation and early during progression TGF-beta acts upon the epithelium as a tumor Suppressor, however at later stages it is often a tumor promoter. Over the years, many studies have focused on the epithelial cell autonomous role for TGF-beta, however, TGF-beta is not strictly limited to this compartment in vivo. Recent studies addressing TGF-beta mediated stromal-epithelial interactions have significantly improved our understanding related to the regulation of cancer. In addition, stromal fibroblast cell autonomous effects have been observed in response to TGF-beta stimulation. According to the current literature and experimental evidence, TGF-beta is a potent ligand that regulates carcinoma initiation, progression and metastasis through a broad and complex spectrum of interdependent interactions. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:29 / 40
页数:12
相关论文
共 50 条
  • [21] TGF-β mediated drug resistance in solid cancer
    Turati, Marta
    Mousset, Alexandra
    Issa, Nervana
    Turtoi, Andrei
    Ronca, Roberto
    CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 71-72 : 54 - 65
  • [22] TGF-β receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-β
    Rojas, Andres
    Padidam, Malla
    Cress, Dean
    Grady, William M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (07): : 1165 - 1173
  • [23] Crosstalk between TGF-β and hedgehog signaling in cancer
    Javelaud, Delphine
    Pierrat, Marie-Jeanne
    Mauviel, Alain
    FEBS LETTERS, 2012, 586 (14) : 2016 - 2025
  • [24] A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
    Huynh, Linh Khanh
    Hipolito, Christopher John
    ten Dijke, Peter
    BIOMOLECULES, 2019, 9 (11)
  • [25] TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
    Caja, Laia
    Dituri, Francesco
    Mancarella, Serena
    Caballero-Diaz, Daniel
    Moustakas, Aristidis
    Giannelli, Gianluigi
    Fabregat, Isabel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [26] TGF-β expression in vulvar cancer
    Karon, Przemyslaw
    Olejek, Anita
    Olszak-Wasik, Katarzyna
    GINEKOLOGIA POLSKA, 2014, 85 (11) : 847 - 851
  • [27] Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
    Pardali, Katenna
    Moustakas, Aristidis
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2007, 1775 (01): : 21 - 62
  • [28] TGF-β in cancer and as a therapeutic target
    Pinkas, Jan
    Teicher, Beverly A.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (05) : 523 - 529
  • [29] Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
    Ungefroren, Hendrik
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (08) : 679 - 693
  • [30] A control engineering approach to understanding the TGF-β paradox in cancer
    Chung, Seung-Wook
    Cooper, Carlton R.
    Farach-Carson, Mary C.
    Ogunnaike, Babatunde A.
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2012, 9 (71) : 1389 - 1397